The Firm recently represented the underwriters, led by J.P. Morgan, Barclays and BofA Merrill Lynch, in an offering of ordinary shares of Perrigo Company plc (“Perrigo”). The offering raised approximately $1 billion of gross proceeds for Perrigo, including the full exercise of the underwriters’ option to purchase additional shares. The Firm also recently represented the underwriters, led by J.P. Morgan, Barclays, BofA Merrill Lynch, HSBC and Wells Fargo Securities, in an offering of $1.6 billion aggregate principal amount of senior notes by Perrigo Finance plc (“Perrigo Finance”), fully and unconditionally guaranteed by Perrigo. In addition, the Firm recently represented J.P. Morgan and Barclays as lead arrangers in connection with Perrigo and Perrigo Finance’s new $1 billion senior unsecured revolving credit facility and new senior unsecured term loan credit facility consisting of separate $300 million and €800 million tranches.
Headquartered in Ireland, Perrigo is a global healthcare supplier that develops, manufactures and distributes over-the-counter and generic prescription pharmaceuticals, nutritional products and active pharmaceutical ingredients. Omega is an over-the-counter healthcare company headquartered in Nazareth, Belgium, with operations in 35 countries across Europe and selected emerging markets.
The Simpson Thacher team for the financing included John C. Ericson, Brian E. Rosenzweig, Paul Bennett, Wabi Jain, Sonya Ho and Meredith Hunt (Capital Markets); Patrick Ryan, Dan Kay and Katharine Thompson (Banking and Credit); Jon Cantor and Jacqueline Barbera (Tax); David Rubinsky and Eric Wolf (Executive Compensation and Employee Benefits); Jennie Getsin (FINRA); Tim Mulvihill (Environmental); and Samantha Himelman (IP).